Bafna Pharmaceuticals Limited Financial Overview
Bafna Pharmaceuticals Limited's market cap is currently ₹3.72B. The company's EPS TTM is ₹1.321; its P/E ratio is 44.48; Bafna Pharmaceuticals Limited is scheduled to report earnings on November 11, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
